The momentum is already visible across the Phoenix metro area, where new chip fabrication plants and data center campuses are under construction. But success brings a critical challenge: how to ...
Desktop Metal, a billion-dollar start-up, promised to revolutionize manufacturing. It went bankrupt, and now has much humbler ...
Solid-state batteries promise greater safety, higher energy density, and new degrees of freedom in cell design. Yet the path from laboratory cell to industrial production is challenging. Laser ...
3d
Top Pharmaceutical API Manufacturer Navigates Shifts in Global Drug Supply and Regulatory Landscape
As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened regulatory scrutiny, the role of the top pharmaceutical API manufacturer has taken on ...
US nuclear isn’t a solo sprint. South Korea’s capital, which is pragmatic, patient, and proficient, could be the alloy that tempers ambition into reality. The reactors will spin, the grids will glow, ...
For years, Suzanne Berger has been a leading advocate for US industry. Now she’s co-directing MIT’s Initiative for New Manufacturing, a platform to help the country make more goods.
AbbVie invests $380 million to build two new API manufacturing facilities in North Chicago while Bora Pharmaceuticals Co., Ltd. and GSK have renewed a five-year global manufacturing partnership.
AbbVie is investing $380 million to build two new active pharmaceutical ingredient manufacturing facilities at its headquarters campus in North Chicago. Construction is set to begin in spring 2026, ...
Part of AbbVie’s vow to invest $100 billion in the U.S. over the next decade, the two Illinois facilities will make active ingredients for next-generation neuroscience and obesity drugs when they ...
Pharmaceutical Technology on MSN
AbbVie announces $380M investment in North Chicago API facilities
Construction is scheduled to commence in spring 2026, with both facilities anticipated to be fully operational by 2029.
AbbVie’s $100 billion splurge on domestic manufacturing and R&D is continuing to come into focus, this time with a $380 million investment in two new active pharmaceutical ingredient manufactur | The ...
AbbVie invests $380m in North Chicago for API manufacturing, creating 300 jobs, boosting US R&D, and expanding domestic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results